Let us show you why the experience matters Contact Us Today

Blog

Pharma’s Practical Next Steps for Social Media

/ October 21, 2016



At this point, most pharmaceutical and life sciences organizations have launched their initial presence on social media. Corporate Facebook pages are up, tweets are going out, even video and image platforms are being embraced.

But, in this age of patient-centricity, with social media providing the capability to directly engage with and learn from key stakeholders, many can’t help but ask, What’s Next? ­

Beyond abstract strategies, for those interested in taking a deeper dive into social media participation, what are some practical (and manageable) steps to get there?

Social Media in the Pharma and Life Sciences Industry Today

We can begin with a brief look at where the industry is today. Based on findings from our recent benchmarking survey we’ve learned:

  • Only 40% of pharma leaders rate their current social media programs as effective
  • There are a number of obstacles facing those interested in expanding social efforts, including:
    • Complying with ambiguous regulations
    • Managing social volume
    • Gaining clarity around permissible interaction
    • Finding experienced staff and partners
  • Pharma leaders are planning to expand social media participation in the following key areas within the next year:
    • Social customer service and product inquiry support
    • Monitoring for market insights
    • Adverse Event detection

What’s Next: Practical Steps for Increased Social Media Participation

Two of our social media experts recently hosted a webinar addressing key social media concerns and go-forward strategies for the pharmaceutical and life sciences industry, including:

  • AE Identification: How to implement a clear process for identification and reporting of potential AEs found in social media:
    • Nuances of social channels
    • Best practices for process design and integration with pharmacovigilance
  • Engagement: Best practices for interacting through social media channels, including:
    • Interaction guidelines
    • Escalation procedures
    • Operational measures, such as response time and interaction quality considerations
  • Technology: When to utilize social media technologies to:
    • Enhance efficiency
    • Deliver relevant reporting
    • Manage growing volume
  • Social Listening: Value of incorporating social media monitoring to enhance a range of critical market insight initiatives:
    • Product launch analysis
    • Patient behaviors
    • Risk management
    • Disease intelligence
    • Competitive analysis

Watch the Webinar On-Demand

Social Rx: Overcoming the Challenges of Social Media Monitoring, Engagement & AE Identification 

View the On-Demand Webinar

Presenters:

  • John MacDaniel, Sr. Director, Voice of the Customer/Digital
  • Phil Baumann, RN BSN, Social Media Strategist

 

 


Tags: , , , , , ,
Subsribe to RSS
Karen Weber Karen Weber

Director, Enterprise & Digital Solutions Strategy

Karen has over 10 years' experience leading marketing strategies, new solution development, and launch initiatives. As Director, Enterprise and Digital Solutions Strategy, Karen is dedicated to enhancing and launching new solutions to meet the needs of healthcare clients within the digital and social media landscape.

READ FULL BIO

Featured Articles

Back to Top